Protein production for COVID-19 vaccine development

29.1f - Ribosome

Service description

Recombinant peptide or protein production could be useful for coronavirus vaccine development: this approach is quite recently being used, as it reduces the allergic and autoimmune response.

This service is designed for Biotech companies developing SARS-CoV-2 new vaccines.

Materials to provide

  • Details about the request

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Production following the specifications validated with the Expert

Get started with your COVID-19 protein production request

Please answer the fields below to be contacted by our team of scientists
section1-3
Back
home